DIA Housing Now Open!
DIA encourages you to select an official DIA hotel for your stay.
Track 3: Medical Affairs and Scientific Communication
With 16 sessions specific to Medical Affairs and Scientific Communication, this track will share insights from medical affairs professionals and medical writers across the globe. Sessions within the track will deliver the necessary skills and best practices for working cross-functionally and compliantly.
Highlights in Medical Affairs
- A focus on patient engagement in medical information
- New business realities for medical affairs professionals and developing compliant medical communications
- Deep dives into the role, responsibilities, and technical skills needed for regulatory medical writers to support the drug and device medical product spectrum
- Featured Topics in Patient Centricity and Career Development
With the emergence of new data sources, comes new questions such as:
- What are the validity and value of these data to patients?
- How do we compliantly communicate this information?
To answer these questions and others, industry is seeking input from scientific and medical thought leaders, as well as regulators. Pharmaceutical and biotechnology industries have increased emphasis on the scientific and clinical principles that support business decisions related to product life cycle management. This evolution has led to expanded competencies for Medical Affairs professionals of pharmaceutical companies outside of their traditional clinical, scientific, and technical roles.
DIA recommends this track and associated sessions to professionals involved in: medical writing, medical communications, and medical science liaisons.
Sessions in Medical Affairs
Monday, June 19
- Globalization of Medical Affairs Departments
- Submission Dossiers: Communications Excellence to Drive Speed and Quality
Tuesday, June 20
-
Paying for Value in Biopharmaceuticals: Trends in the United States
- The New Business Reality for the Medical Science Liaison Community
- Best Practice for Advisory Committee Meeting Preparation
- Building the Medical Strategy and Tactics
- Medical Information and the Patient: Effective Communication and Handling of Requests
- Creating Adaptive Contents for a Multichannel World
- Effective Collaboration Between Sponsors and Medical Writing Vendors
Wednesday, June 21
-
International Regulatory Convergence
- How to Engage Patients Within Medical Affairs
- Digital Innovations for Medical Information Contact Centers
- FDA Update on Prescription Drug Promotion
- EMA Policy 0070: A Game Changer for Industry
- Writing of Layperson Summaries of Clinical Trial Results According to the EU: Regulation and its Impact on Global Pharmaceutical Activities
- Off-Label Communications to Health Care Providers and Consumers
- Digital Channels and Artificial Intelligence in Medical Information and Communications
Thursday, June 22
-
FDA Forum
- Driving International Awareness and Use of Regulatory Writing Guidelines: Case Studies of the Clarity and Openness in Reporting (CORE) Reference Guidelines
Need More on Medical Affairs and Scientific Communications?
DIA’s Learning portfolio offers multiple face-to-face and online opportunities. Compliant medical communications for a global market demands a comprehensive action-plan to disseminate information and a need to efficiently evaluate potential sources of medical information across the increasingly complex network for media channels. DIA Learning solutions will provide individuals working in medical communications, medical information, medical writing, and field-based medical teams (medical science liaisons) with the most current information and skills needed to be successful in this rapidly changing field.
Click to learn about the Medical Communications eLearning Program designed for professionals new to the field. DIA offers group rates to companies interested in purchasing eLearning modules for multiple users within a team.
Upcoming Medical Writing Face-to-Face Learning
- Clinical Statistics for Nonstatisticians
- Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America, and Other Emerging Markets
- Medical Affairs and Scientific Communications Forum 2018